Condition
Type II Diabetes Mellitus clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Type II Diabetes Mellitus clinical trials that are recruiting, at sites in 7 countries (most in Pakistan (3), Afghanistan (2), United States (2)). By phase: Phase 4 (1), Phase 1 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 7Countries
Newest Type II Diabetes Mellitus clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Effect of kidney function on GL0034 exposure in adults with type 2 diabetes | Phase 1 | Miami, Florida and 2 other locations | Recruiting | Feb 4, 2026 |
| Community participatory learning to prevent and control type 2 diabetes in rural Kabul | — | Kabul, Kabul | Recruiting | Jan 20, 2026 |
| Weekly GL0034 injections for overweight or obese adults with type 2 diabetes | Phase 2 | Little Rock, Arkansas and 20 other locations | Recruiting | Dec 15, 2025 |
| Community engagement to prevent Type II diabetes in urban Pakistan | — | Karachi, Sindh | Recruiting | Aug 26, 2024 |
| Community participatory groups to prevent and control Type II diabetes in rural Peshawar and Swabi | — | Peshawar, KPK | Recruiting | Aug 19, 2024 |
| Empagliflozin with or without metformin for safety and tolerability in adults with Type 2 diabetes | Phase 4 | Kabul, Afghanistan and 5 other locations | Recruiting | Dec 20, 2021 |
All recruiting trials (6)
-
Effect of kidney function on GL0034 exposure in adults with type 2 diabetes
We will give a single dose of GL0034 to adults with type 2 diabetes who have different levels of kidney function to see if kidney problems change how the body handles the drug.
-
Community participatory learning to prevent and control type 2 diabetes in rural Kabul
This project will try a community-led participatory learning and action program to prevent and control type 2 diabetes among adults living in rural Kabul.
-
Weekly GL0034 injections for overweight or obese adults with type 2 diabetes
This study will try weekly GL0034 injections to see if they lower HbA1c and are tolerated in overweight or obese adults with type 2 diabetes.
-
Community engagement to prevent Type II diabetes in urban Pakistan
This study is trying a community-based program in urban Karachi to see if it can help prevent and manage Type II diabetes for people aged 20 and older.
-
Community participatory groups to prevent and control Type II diabetes in rural Peshawar and Swabi
This project will try a community group-based Participatory Learning and Action program to help prevent and control Type II diabetes among adults living in rural Peshawar and Swabi, Pakistan.
-
Empagliflozin with or without metformin for safety and tolerability in adults with Type 2 diabetes
This project will try empagliflozin, with or without metformin, in adults with Type 2 diabetes to see if it is safe and well tolerated in routine clinical care at participating centers.
Related topics
Quick answers
How many Type II Diabetes Mellitus clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 7 countries. The most sites are in Pakistan (3 trials), Afghanistan (2 trials), United States (2 trials), Kenya (1 trial), Nigeria (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1, Phase 1: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.